Tadalafil Tablet, Film Coated
Product Images NDC 71335-1620

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71335-1620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351620)

This is a description for Tadalafil 10mg tablets, manufactured by Intas Pharmaceuticals Limited. The tablets are oval shaped and yellow in color with the imprint "FJ3". They are packaged in a bottle of 30 tablets and should be stored at room temperature. These tablets are similar to the branded drug Cialis 10mg and should be kept out of reach of children.*

FDA Label Image

Figure (Tadalafil Figure1)

The text is a table with blood pressure measurements for standing and supine positions, comparing Tadalafil with Placebo. It shows the difference between the two drugs in millimeters of mercury (mmHg). Time is also displayed on the table in hours.*

FDA Label Image

Figure (Tadalafil Figure2)

This is a data table showing information about a medical study for a combination of Tadalafil 20mg and doxazosin 8mg vs Placebo and doxazosin 8mg. The table includes time post-dose and various values for the treatment groups. There is no further information available.*

FDA Label Image

Figure (Tadalafil Figure3)

FDA Label Image

Figure (Tadalafil Figure4)

This is a chart that shows the concentration of tadalafil in plasma over time, measured in micrograms per liter (ug/L). There are three lines on the chart representing different dosages: a single 20-mg dose, a single 5-mg dose, and a once-daily 5-mg dose following 5 consecutive days of administration. The chart also includes a time axis in hours up to 120 hours (or 5 days) after dosing.*

FDA Label Image

Figure 5 (Tadalafil Figure5)

The text describes a chart or graph showing the change from baseline in IPSS (International Prostate Symptom Score) total scores in patients over a duration of treatment in weeks. The treatment involves tadalafil and placebo, and the chart indicates a statistically significant improvement with tadalafil compared to placebo.*

FDA Label Image

Figure 6 (Tadalafil Figure6)

FDA Label Image

Figure 7 (Tadalafil Figure7)

FDA Label Image

Figure 8 (Tadalafil Figure8)

FDA Label Image

Chemical Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.